Honoré L H, Koch M, Brown L B
Department of Pathology, University of Alberta, Edmonton, Canada.
Gynecol Obstet Invest. 1991;32(2):98-101. doi: 10.1159/000293004.
The possible link between oral contraceptives (OCs) and cervical adenocarcinoma was tested by a case-case study of prior and current OC use in women with adenocarcinoma and squamous cell carcinoma. Cases were matched by age, year of diagnosis, and stage of the lesion, and personal, reproductive, and contraceptive data were obtained by mailed questionnaires. Except for smoking, which was significantly more prevalent in women with squamous cell carcinoma, the two groups were identical, with similar OC exposure. This study does not support the idea that OCs modulate the expression of cervical neoplasia in favor of adenocarcinoma.
通过一项病例对照研究,对患有腺癌和鳞状细胞癌的女性既往和当前口服避孕药(OCs)的使用情况进行检测,以探究口服避孕药与宫颈腺癌之间可能存在的联系。病例按照年龄、诊断年份和病变阶段进行匹配,并通过邮寄问卷获取个人、生殖和避孕数据。除吸烟在鳞状细胞癌女性中更为普遍外,两组在口服避孕药暴露情况相似,其他方面均相同。该研究不支持口服避孕药调节宫颈肿瘤形成以利于腺癌发生这一观点。